The little pink pill recently got a retail boost. Addyi, a drug that treats low libido in premenopausal women, has been on the market for more than a decade after a controversial approval .
But in December the Food and Drug Administration expanded its use, approving the daily drug for all women under 65.  More women than ever now could qualify for the pill — and its maker, Sprout Pharmaceuticals, made it easy for them to find out. On its Instagram account, in Facebook ads, and on its website, Sprout shared how women could get a quick consult for an Addyi prescription: With a special code, PINKPILL, they could get a telehealth visit for just $10.  Drugmakers have long used discount coupons to encourage patients to use their high-cost medications.
STAT News published a clinical update in Research Highlights on 23 Apr 2026.
The item focuses on STAT+: Will bargain-basement telehealth visits help pharma drive drug scripts?.
Review the original article for the full source wording and details.